A Phase I Study of Episcleral Dexamethasone for Treatment of Macular Edema

NCT04005430 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

1

Enrollment

INDUSTRY

Sponsor class

Conditions

Refractory Diabetic Macular Edema

Interventions

DRUG: Episcleral Dexamethasone

Sponsor

Targeted Therapy Technologies, LLC